arXiv ·
A new brain tumor segmentation method based on convolutional neural networks is proposed for the BraTS-GoAT challenge. The method employs the MedNeXt architecture and model ensembling to segment tumors in brain MRI scans from diverse populations. Experiments on the unseen validation set demonstrate promising results with an average DSC of 85.54%.
arXiv ·
Researchers from MBZUAI have developed MMRINet, a Mamba-based neural network for efficient brain tumor segmentation in MRI scans. The model uses Dual-Path Feature Refinement and Progressive Feature Aggregation to achieve high accuracy with only 2.5M parameters, making it suitable for low-resource clinical environments. MMRINet achieves a Dice score of 0.752 and HD95 of 12.23 on the BraTS-Lighthouse SSA 2025 benchmark.
KAUST ·
KAUST Discovery highlights the contributions of Magistretti to the field of neuroenergetics. His research explores the cellular and molecular basis of brain energy metabolism and brain imaging. Magistretti's group discovered mechanisms underlying the coupling between neuronal activity and energy consumption, revealing the role of astrocytes. Why it matters: Understanding brain energy metabolism and the role of glial cells can advance brain imaging techniques and our understanding of neuronal processes.
KAUST ·
Dr. Yves Agid from the ICM Paris Institute of Translational Neuroscience lectured at KAUST's 2018 Winter Enrichment Program about the role of glial cells in brain function and behavior. He highlighted that glial cells, often overlooked in research, are crucial for neural synchronization and overall intelligence. Dysfunction of glial cells can induce pathologies like Alzheimer's and Parkinson's disease. Why it matters: The lecture underscored the importance of studying glial cells in addition to neurons for understanding and treating neurodegenerative disorders, which could influence future research directions at KAUST and in the region.
KAUST ·
KAUST researchers collaborated with the Blue Brain Project to study astrocytes, brain cells crucial for memory and learning. Dr. Corrado Calì produced 3D models of astrocytes using serial block-face electron microscopy to understand their structure. The study, published in Progress in Neurobiology, reveals how lactate transfer from astrocytes to neurons contributes to brain energy usage. Why it matters: Understanding astrocyte function could lead to new drugs for treating conditions like stroke and Alzheimer's disease by improving brain cell function.
KAUST ·
KAUST researchers are exploring the link between nutrition and brain-energy metabolism to address cognitive decline, dementia, and Alzheimer’s disease. Dr. Pierre Magistretti and Dr. Johannes le Coutre are collaborating on ways to merge brain-energy metabolism research into the field of nutrition. They published an article entitled “Goals in Nutrition Science 2015-2020” in the journal Frontiers in Nutrition. Why it matters: This research could lead to nutritional interventions to hinder or prevent cognitive decline, offering a new approach beyond traditional drug treatments.
KAUST ·
KAUST researchers developed a statistical approach to improve the identification of cancer-related protein mutations by reducing false positives. The method uses Bayesian statistics to analyze protein domain data from tumor samples, accounting for potential errors due to limited data. The team tested their method on prostate cancer data, successfully identifying a known cancer-linked mutation in the DNA binding protein cd00083. Why it matters: This enhances the reliability of cancer research at the molecular level, potentially accelerating the discovery of new therapeutic targets.